| Role for NLRP3 inflammasome–mediated, IL-1β–dependent responses in severe, steroid-resistant asthma RY Kim, JW Pinkerton, AT Essilfie, AAB Robertson, KJ Baines, AC Brown, ... American journal of respiratory and critical care medicine 196 (3), 283-297, 2017 | 359 | 2017 |
| MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 RY Kim, JC Horvat, JW Pinkerton, MR Starkey, AT Essilfie, JR Mayall, ... Journal of Allergy and Clinical Immunology 139 (2), 519-532, 2017 | 206 | 2017 |
| Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis B Hosseini, BS Berthon, A Saedisomeolia, MR Starkey, A Collison, ... The American journal of clinical nutrition 108 (1), 136-155, 2018 | 202 | 2018 |
| Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease A Chen-Yu Hsu, MR Starkey, I Hanish, K Parsons, TJ Haw, LJ Howland, ... American journal of respiratory and critical care medicine 191 (9), 1012-1023, 2015 | 148 | 2015 |
| Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma AT Essilfie, JC Horvat, RY Kim, JR Mayall, JW Pinkerton, EL Beckett, ... Thorax 70 (5), 458-467, 2015 | 141 | 2015 |
| Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma PM Hansbro, RY Kim, MR Starkey, C Donovan, K Dua, JR Mayall, G Liu, ... Immunological reviews 278 (1), 41-62, 2017 | 132 | 2017 |
| Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy EE To, R Vlahos, R Luong, ML Halls, PC Reading, PT King, C Chan, ... Nature communications 8 (1), 69, 2017 | 131 | 2017 |
| Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology JC Horvat, MR Starkey, RY Kim, S Phipps, PG Gibson, KW Beagley, ... Journal of allergy and clinical immunology 125 (3), 617-625. e6, 2010 | 129 | 2010 |
| Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease JC Horvat, MR Starkey, RY Kim, KW Beagley, JA Preston, PG Gibson, ... The Journal of Immunology 184 (8), 4159-4169, 2010 | 115 | 2010 |
| Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells JA Preston, AN Thorburn, MR Starkey, EL Beckett, JC Horvat, MA Wade, ... European Respiratory Journal 37 (1), 53-64, 2011 | 111 | 2011 |
| MicroRNA-125a and-b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD ACY Hsu, K Dua, MR Starkey, TJ Haw, PM Nair, K Nichol, N Zammit, ... JCI insight 2 (7), 2017 | 109 | 2017 |
| Th2 cytokine antagonists: potential treatments for severe asthma PM Hansbro, GV Scott, AT Essilfie, RY Kim, MR Starkey, DH Nguyen, ... Expert Opinion on Investigational Drugs 22 (1), 49-69, 2013 | 100 | 2013 |
| Role of iron in the pathogenesis of respiratory disease MK Ali, RY Kim, R Karim, JR Mayall, KL Martin, A Shahandeh, F Abbasian, ... The international journal of biochemistry & cell biology 88, 181-195, 2017 | 93 | 2017 |
| TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life EL Beckett, S Phipps, MR Starkey, JC Horvat, KW Beagley, PS Foster, ... PloS one 7 (6), e39460, 2012 | 89 | 2012 |
| A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease TJ Haw, MR Starkey, PM Nair, S Pavlidis, G Liu, DH Nguyen, AC Hsu, ... Mucosal immunology 9 (4), 859-872, 2016 | 79 | 2016 |
| Murine models of infectious exacerbations of airway inflammation MR Starkey, AG Jarnicki, AT Essilfie, SL Gellatly, RY Kim, AC Brown, ... Current opinion in pharmacology 13 (3), 337-344, 2013 | 76 | 2013 |
| Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization MJ Gold, PR Hiebert, HY Park, D Stefanowicz, A Le, MR Starkey, A Deane, ... Mucosal immunology 9 (3), 809-820, 2016 | 73 | 2016 |
| Suppressor of cytokine signaling (SOCS) 5 ameliorates influenza infection via inhibition of EGFR signaling L Kedzierski, MD Tate, AC Hsu, TB Kolesnik, EM Linossi, L Dagley, ... Elife 6, e20444, 2017 | 70 | 2017 |
| Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease MR Starkey, AT Essilfie, JC Horvat, RY Kim, DH Nguyen, KW Beagley, ... Mucosal immunology 6 (3), 569-579, 2013 | 70 | 2013 |
| Pulmonary group 2 innate lymphoid cells: surprises and challenges MR Starkey, ANJ McKenzie, GT Belz, PM Hansbro Mucosal immunology 12 (2), 299-311, 2019 | 68 | 2019 |
Hansbro PVerified email at newcastle.edu.au
